檢索結果 - Aurelien Marabelle
- Showing 1 - 20 results of 40
- Go to Next Page
-
1
-
2
-
3
755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy... 由 Aurélien Marabelle, John Mumm, Douglas Orr, Alexander I Spira, Elizabeth C Moser, Deb Kientop
發表在 Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
4
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma 由 Aurélien Marabelle, Laurence Albiges, Angelo Paci, Cécile Dalban, David Combarel, Sophie Broutin, Christophe Maritaz, Louis Blondel
發表在 Journal for ImmunoTherapy of Cancer (2025-01-01)獲取全文
Article -
5
In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CA... 由 Béatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, Régine Vivien, Raphaël Rousseau, Aurélien Marabelle, Christophe Caux, Henri Vié
發表在 Journal of Immunology Research (2015-01-01)獲取全文
Article -
6
Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation? 由 Selma Addou, Clémentine Sarkozy, Julien Lazarovici, Stéphane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurélien Marabelle, Jean-Marie Michot
發表在 Human Vaccines & Immunotherapeutics (2021-10-01)獲取全文
Article -
7
-
8
Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade 由 Olivier Lambotte, Jean-Marie Michot, Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Romain Guitton, Ariane Laparra, Noemie Chanson, Sabine Messayke
發表在 Journal for ImmunoTherapy of Cancer (2025-09-01)獲取全文
Article -
9
-
10
315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody 由 Aurélien Marabelle, Carlos Gomez-Roca, Pierre Ferre, Eric Chetaille, Aurelie Petain, Celine Thuilliez, Isabelle Vandenberghe, Francisco Cruzalegui, Asmaa Boudribila, Mariya Pavlyuk
發表在 Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
11
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors 由 Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Yohann Loriot, Julia Delahousse, Kaïssa Ouali, Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin
發表在 Journal for ImmunoTherapy of Cancer (2024-05-01)獲取全文
Article -
12
316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A 由 Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché
發表在 Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
13
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice 由 Aurélien Marabelle, Louis Meyblum, Lambros Tselikas, Thierry de Baere, Sandrine Susini, Fréderic Deschamps, Baptiste Bonnet, Céline Chevaleyre, Benoit Jego, Dimitri Kereselidze, Vincent Lebon, Charles Truillet
發表在 Journal for ImmunoTherapy of Cancer (2023-11-01)獲取全文
Article -
14
Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy 由 Aurélien Marabelle, Samy Ammari, Eric Deutsch, Michael Farwell, Heiko Schöder, Lawrence H Schwartz, Binsheng Zhao, Laurent Dercle, Jeremy McGale, Shawn Sun, Randy Yeh, Fatima-Zohra Mokrane
發表在 Journal for ImmunoTherapy of Cancer (2022-09-01)獲取全文
Article -
15
Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies 由 Aurélien Marabelle, Laurence Zitvogel, Lambros Tselikas, Thierry de Baere, Thomas Isoardo, Sandrine Susini, Karine Ser-Le Roux, Mélanie Polrot, Julien Adam, Mathieu Rouanne, Laurence Moine, Fréderic Deschamps
發表在 Journal for ImmunoTherapy of Cancer (2020-05-01)獲取全文
Article -
16
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors 由 Ben Tran, Richard D. Carvajal, Aurelien Marabelle, Sandip Pravin Patel, Patricia M. LoRusso, Erik Rasmussen, Gloria Juan, Vijay V. Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski
發表在 Journal for ImmunoTherapy of Cancer (2018-09-01)獲取全文
Article -
17
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers 由 Francois-Xavier Danlos, Aurélien Marabelle, Roberto Ferrara, Benjamin Besse, Lydie Cassard, Nathalie Chaput, Aude Desnoyer, Boris Duchemann, Marie Naigeon, Edouard Auclin, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Laura Mezquita, Caroline Caramella
發表在 Journal for ImmunoTherapy of Cancer (2022-02-01)獲取全文
Article -
18
Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types 由 Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard
發表在 Cancer Medicine (2020-04-01)獲取全文
Article -
19
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer 由 Caroline Robert, Aurélien Marabelle, Fabrice Barlesi, Samy Ammari, David Planchard, Siham Farhane, Paul-Henry Cournède, Pierre Decazes, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Antoine de Prévia, Hugues Talbot, Florian Guisier, Tony Ibrahim, Pierre Vera, Nathalie Lassau
發表在 Journal for ImmunoTherapy of Cancer (2023-09-01)獲取全文
Article -
20
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors 由 Yan Zhang, Andrés Cervantes, Stephane Champiat, Aurélien Marabelle, Patricia LoRusso, Jason J Luke, Robert Haddad, David J Pinato, Dejan Juric, María de Miguel, Won Seog Kim, Xiaobin Yuan, Peter J Hosein, Anupam M Desai, Yuanxin Rong
發表在 Journal for ImmunoTherapy of Cancer (2025-02-01)獲取全文
Article
